Skip to main content
. 2007 Feb;9(1):7–11. doi: 10.2353/jmoldx.2007.060186

Table 1.

Comparison of Current Technologies That Allow in Situ Analysis of Cancer Biomarkers

Technologies Tissue penetration depth Detection sensitivity Multiplexing capability Quantification capability
Organic fluorophores High Low Medium Low
Quantum dots Medium High High High
Immunoenzyme assays High High Single parameter Low
Plasmon resonant nanoparticles Very low High High High
Nanogold with silver enhancement High High Single parameter Low